As many others already have, call the T/A. What they say is a fact, the O/S has not changed since that tiny increase. This 100k if used by the company could have been used for the dCellVax preclinical trial, which appear to be completed or close to.
2,916,286,718 O/S as of March 31st 2014;
2,951,045,145 O/S as of June 30, 2014.
That's an increase of 34,758,427
----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
On July 1, 2014 the Company Issued 45,000,000 Common Shares (“Shares”) for consideration of $100,000.
The Shares were issued pursuant to Section 4(a) (2) of the Securities Act of 1933, as amended (the “Act”). No underwriters were retained to serve as placement agents for the sale. The shares were sold directly through our management. No commission or other consideration was paid in connection with the sale of the shares. There was no advertisement or general solicitation made in connection with this Offer and Sale of Shares. A legend was placed on the certificate that evidences the Shares stating that the Shares have not been registered under the Act and setting forth or referring to the restrictions on transferability and sale of the Shares. The funds received were utilized for general corporate purposes.
News 
Market Data 
Discover 
